Federal contractor profile
CYTOVALE INC
UEI TG7HM4HD8594CAGE 6PS42
Overview
- Legal name
- CYTOVALE INC
- Registered location
- SAN FRANCISCO, CA, USA
- Primary NAICS
- 339112 — Surgical and Medical Instrument Manufacturing
- Latest award activity
- Sep 8, 2025
Read company summary
CYTOVALE INC is associated with UEI TG7HM4HD8594 and CAGE 6PS42 in public federal records. AcornBids currently links 2 prime awards totaling $1.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 339112 (Surgical and Medical Instrument Manufacturing). Its public SAM.gov registration lists SAN FRANCISCO, CA, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CYTOVALE INC
- UEI
- TG7HM4HD8594
- CAGE
- 6PS42
- Registered address
- 150 EXECUTIVE PARK BLVD STE 4100, SAN FRANCISCO, CA, 94134, USA
- Registration status
- E
- Primary NAICS
- 339112 — Surgical and Medical Instrument Manufacturing
- SAM updated
- Oct 10, 2025
- Registration expires
- Oct 10, 2025
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50122C00059PATCHD, INC R&D FOR CLINICAL VALIDATION OF AN AT-HOME, DEEP-LEARNING BASED, SEPSIS MONITORING SYSTEM AOI#2 INFECTION SEVERITY & SOLVING SEPSIS | Department of Health and Human Services | $437.8K | Sep 28, 2022 | Aug 31, 2025 |
| 75A50123C00066CYTOVALE: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF THE INTELLISEP TEST ON CLINICAL DECISION-MAKING AND ITS POTENTIAL TO AID IN IMPROVING SEPSIS RISK… | Department of Health and Human Services | $599.6K | Sep 19, 2023 | May 30, 2025 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Oct 10, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Not available |
| Entity start | Not available |
Registered industries
- 27 — 27
- 2X — 2X
Registered products and services
- 339112Y — 339112Y
- 541714Y — 541714Y
- 541715E — 541715E
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit